Why Is Summit Therapeutics Inc. (SMMT) Stock Down Today?

Summary

Summit Therapeutics Inc. (SMMT) is trading down -1.53% at $14.84, reflecting a negative shift in investor sentiment today. The stock opened at $14.93 and has moved between $14.42 and $15.21 so far.

Trading volume is 5248997, which is 27% above its average, and the price action suggests selling interest.

Technically, SMMT is trading below its 50-day moving average of $18.98 and below its 200-day moving average of $18.59, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns SMMT a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +6.00% in 1 month ($15.73), +49.30% in 1 year ($22.16), and +101.51% in 5 years ($29.90).

View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.